Live Breaking News & Updates on Jianzhong zhang

Stay informed with the latest breaking news from Jianzhong zhang on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Jianzhong zhang and stay connected to the pulse of your community

Lynk Pharmaceuticals Announces First Atopic Dermatitis Patient Dosed in Phase Ⅲ Clinical Study of LNK01001

Lynk Pharmaceuticals Announces First Atopic Dermatitis Patient Dosed in Phase Ⅲ Clinical Study of LNK01001
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

China , Boston , Massachusetts , United-states , Peking , Beijing , Cheng-zhou , Zhejiang , Shanghai , Australia , Hangzhou , Henry-wu

Chinese GPU Maker Moore Threads Lays Off Workers, Restructures After US Sanctions

Moore Threads was sanctioned by the U.S. government last month, and the layoffs are a direct response.

United-states , China , Chinese , American , Jianzhong-zhang , Ai-strategy-group , Metaverse-computing-strategy-group , Nvidia , Linkedin , Moore-threads , China-general-manager , Metaverse-computing-strategy

LNK01001 Achieves Primary End Point in Phase II Trial for Atopic Dermatitis

Patients given LNK01001 showed significant improvement in Eczema Area and Severity Index scores over placebo.

Peking , Beijing , China , Chinese , Jianzhong-zhang , Lynk-pharmaceuticals-co-ltd , Dermatology-division-of-the-chinese-medical-association , Dermatology-department-at-peking-university-people-hospital , Eczema-area , Severity-index , Global-assessment , Dermatology-division

Lynk Pharmaceuticals Announced Positive Topline Data from Phase II Clinical Trial of LNK01001 in the Treatment of Atopic Dermatitis

Lynk Pharmaceuticals Announced Positive Topline Data from Phase II Clinical Trial of LNK01001 in the Treatment of Atopic Dermatitis
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

China , Peking , Beijing , Hangzhou , Zhejiang , Chinese , Jianzhong-zhang , Henry-wu , Lynk-pharmaceuticals-co-ltd , Lynk-pharmaceuticals , Dermatology-division-of-the-chinese-medical-association , Dermatology-department-at-peking-university-people-hospital

Kintor Pharma Announces Completion of First Patient Enrollment in Long-term Safety Phase III Trial of KX-826 for Treatment of AGA

/PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...

United-states , China , Suzhou , Jiangsu , Peking , Beijing , Kintor-pharma , Jianzhong-zhang , Prnewswire-kintor-pharmaceutical-limited-pharma , Kintor-pharmaceutical , University-people-hospital , China-national-medical-products-administration

Crisaborole Ointment Found to be Effective for Atopic Dermatitis in Younger Patients from China, Japan

New phase 3 data on patients with eczema in China and Japan showed that crisaborole, 2%, was efficacious and safe in patients aged 2 and older, lining up with data from studies done in Western countries.

China , Japan , Peking , Beijing , Japanese , Chinese , Ann-dermatol , Jianzhong-zhang , University-people-hospital , Peking-university-people , Eczema-area , Severity-index

Kintor Pharma Announces 2022 Annual Results and -2-

DJ Kintor Pharma Announces 2022 Annual Results and Recent Business Progress EQS Newswire / 31/03/2023 / 10:10 UTC+8 Kintor Pharma Announces 2022 Annual Results and Recent Business Progress

China , Gusu , Guangdong , Shanghai , Jishi , Jilin , Suzhou , Jiangsu , Hong-kong , Peking , Beijing , Chinese

Kintor Pharma Announces 2022 Annual Results and Recent Business Progress

DJ Kintor Pharma Announces 2022 Annual Results and Recent Business Progress EQS Newswire / 31/03/2023 / 10:10 UTC+8 Kintor Pharma Announces 2022 Annual Results and Recent Business Progress

China , Jishi , Guangdong , Shanghai , Gusu , Peking , Beijing , Hong-kong , Suzhou , Jiangsu , Jilin , Chinese

Kintor Pharmaceutical : Pharma Announces 2022 Annual Results and Recent Business Progress

Suzhou, March 30, 2023 - Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced business... | March 30, 2023

China , Jishi , Guangdong , Hong-kong , Shanghai , Suzhou , Jiangsu , Gusu , Jilin , Peking , Beijing , Chinese

Kintor Pharma Announces 2022 Annual Results and Recent Business Progress

SUZHOU, China, March 30, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today... | March 30, 2023

China , Shanghai , Gusu , Guangdong , Hong-kong , Jishi , Peking , Beijing , Suzhou , Jiangsu , Jilin , Chinese